FDA
-
-
-
-
-
-
-
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
-
-
-
-
-
-
-
Abbott receives CE Mark for dual-energy heart rhythm catheter in Europe
-
-
-
-
-
-
-
Abbott Reports Second-Quarter 2025 Results
-
-
-
-
-
-
-
Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $133 at Piper Sandler
-
-
-
-
-
-
-
Abbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression
-
322,966 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

